Time on boards
- Boards served
- 2
- Current seats
- 2
- Board service
- 5 years
- Director since
- 2023
5 years of board service in total across 2 boards, counting each seat separately. Longest: Vor Biopharma Inc., 3 years.
Vor Biopharma Inc.
Director
Upstream Bio Inc.
Director
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Feb 5, 2025 | Tango Therapeutics Inc. | Open-market sale | −3,948 | $3.16 | $12,476 |
| Feb 4, 2025 | Tango Therapeutics Inc. | Open-market sale | −4,284 | $2.99 | $12,809 |
| Feb 3, 2025 | Tango Therapeutics Inc. | Grant or award | +26,119 | — | — |
| Feb 7, 2024 | Tango Therapeutics Inc. | Open-market sale | −1,817 | $12.62 | $22,931 |
| Feb 6, 2024 | Tango Therapeutics Inc. | Open-market sale | −1,908 | $12.56 | $23,964 |
| Feb 1, 2024 | Tango Therapeutics Inc. | Grant or award | +39,413 | — | — |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.